- Topics
- Regions
- Events
- Webcasts
- Resources
- CW Exclusives
- Membership
“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
Daimler projects over $2B to resolve U.S. emission cheating allegations
By 
Aaron Nicodemus2020-08-18T21:12:00
Daimler AG, the parent company of car maker Mercedes-Benz, predicts it will spend over $2 billion to settle emission tampering allegations by U.S. regulators and a related class-action lawsuit.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleDaimler, U.S. authorities reach $1.5B proposed emissions settlement
Daimler AG and subsidiary Mercedes-Benz USA have reached a proposed settlement with U.S. authorities totaling $1.5 billion in fines and other costs to resolve emissions-cheating allegations.
-
Article
Daimler appoints chief compliance officer
German automotive corporation Daimler announced the appointment of Dr. Wolfgang Bartels as chief compliance officer. Dr. Bartels takes over for Olaf Schick, who is to become the CFO of Daimler Greater China.
-
Article
Analysis: VW ‘deliberately immoral’ ruling pushes governance lessons
A look at a recent court case against car manufacturer Volkswagen once again places the company in the spotlight but, perhaps more importantly, offers some lessons in how to live up to shareholder expectations of good governance that protects their investment.
More from Regulatory Enforcement
-
PremiumSEC charge against CCO in penny stock scheme raises questions about gatekeeper liability
A recent complaint by the Securities and Exchange Commission against the chief compliance officer of a Chicago-based investment firm contains some of the most worrisome examples of how CCOs can be found liable for misconduct at their firm.
-
News BriefWalgreens ducked compliance, filled fake opioid prescriptions, DOJ suit alleges
Walgreens skimped on compliance and filled millions of prescriptions for narcotics that weren’t medically necessary, the Department of Justice alleged in a complaint against the company, first brought by four whistleblowers.
-
News BriefFRC discloses probe of KPMG over 2022 audit of gambling company Entain
The U.K. Financial Reporting Council disclosed an investigation into KPMG’s audit of international sports betting and gambling company Entain Group.